Post by
Golddetector on Jan 20, 2022 9:24am
Oversold
Tbp is way oversold. Best part this happened ahead of major milestones for the company. They are turning to revenue with Reduvo approval expected the q. As for QIXLEEF that is really the big one once comparison of head to head trial against opioid is released. How much that will worth?? Mc at 50 million is a jock. Hold tight longs
Comment by
Elouali on Jan 20, 2022 10:10am
The number of shares issued is way bigger than the market cap, even with an approval it will may reach 0.20 cents